270 related articles for article (PubMed ID: 3740023)
1. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
Rasmussen M; Fenger C; Kronborg O
Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
[TBL] [Abstract][Full Text] [Related]
3. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
4. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal neoplasia: a multicenter study in Israel.
Odes HS; Rozen P; Ron E; Bass D; Bat L; Keren S; Fireman Z; Shemesh E; Krugliak P; Fraser G
Isr J Med Sci; 1992 Jan; 28(1 Suppl):21-8. PubMed ID: 1733906
[TBL] [Abstract][Full Text] [Related]
6. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program.
Shapero TF; Hoover J; Paszat LF; Burgis E; Hsieh E; Rothwell DM; Rabeneck L
Gastrointest Endosc; 2007 Apr; 65(4):640-5. PubMed ID: 17173913
[TBL] [Abstract][Full Text] [Related]
9. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
[TBL] [Abstract][Full Text] [Related]
10. A cost analysis of screening methodology for family members of colorectal cancer patients.
Rozen P; Ron E
Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
12. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
Adamsen S; Kronborg O
Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
[TBL] [Abstract][Full Text] [Related]
13. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
15. Screening for colonic neoplastic lesions using flexible sigmoidoscopy in employees of a nuclear research center and members of collective settlements.
Niv Y; Gold B; Fraser GM
Isr J Med Sci; 1996 Dec; 32(12):1167-72. PubMed ID: 9007146
[TBL] [Abstract][Full Text] [Related]
16. Screening for colon malignancy with colonoscopy.
Lieberman DA; Smith FW
Am J Gastroenterol; 1991 Aug; 86(8):946-51. PubMed ID: 1858758
[TBL] [Abstract][Full Text] [Related]
17. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
18. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer in Russian-speaking Jewish emigrés: community-based screening.
Vadlamani A; Maher JF; Shaete M; Smirnoff A; Cameron DG; Winkelmann JC; Goldberg SJ
Am J Gastroenterol; 2001 Sep; 96(9):2755-60. PubMed ID: 11569707
[TBL] [Abstract][Full Text] [Related]
20. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
